These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1345378)

  • 1. Malignant tumours after renal transplantation.
    Tóth A; Alföldy F; Járay J; Hidvégi M; Perner F
    Acta Chir Hung; 1992-1993; 33(3-4):211-6. PubMed ID: 1345378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
    Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
    Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA.
    Sheil AG; Disney AP; Mathew TH; Amiss N; Excell L
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1111-2. PubMed ID: 1989161
    [No Abstract]   [Full Text] [Related]  

  • 4. Kidney transplantation and malignant diseases.
    Grosmanová T; Tomsu M; Konecný K; Pesula E; Bachleda P
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():335-42. PubMed ID: 1840356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumors and kidney transplantation].
    Brünisholz M; Hodel K; Brunner FP; Harder F; Torhorst J; Thiel G
    Schweiz Med Wochenschr; 1984 Dec; 114(51):1915-24. PubMed ID: 6395328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies in renal transplantation: an unmet medical need.
    Dantal J; Pohanka E
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
    Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
    Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches towards individualized immune intervention.
    Giese T; Sommerer C; Zeier M; Meuer S
    Dig Dis; 2010; 28(1):45-50. PubMed ID: 20460889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-transplantation lymphoproliferation in patients with intensive immunosuppression].
    Vavrinová H; Viklický O; Lácha J; Housa D; Hosková L; Teplan V
    Vnitr Lek; 2006 Jun; 52(6):645-8. PubMed ID: 16871771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
    Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
    Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant neoplastic pathology in patients given a kidney transplant].
    Prati GF; Recchia G; Dean P; Boschiero L; Faccincani L; Muolo A
    Chir Ital; 1987 Jun; 39(3):298-302. PubMed ID: 3308155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT].
    Stallone G; Infante B; Schena A; Grandaliano G; Di Paolo S; Scolari MP; Stefoni S; Zanazzi M; Salvadori M; Savazzi AM; Albertazzi A; Cornella C; Turello E; Schena FP
    G Ital Nefrol; 2003; 20(6):611-4. PubMed ID: 14732914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.
    Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer after kidney transplantation and immunosuppression].
    Ivanovski N; Popov Z; Kolevski P; Cakalaroski K; Antova Z; Spasovski G; Vlckova-Laskovska M; Zografski G
    Ann Urol (Paris); 2000 Oct; 34(5):336-9. PubMed ID: 11144722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant neoplasms and kidney transplantation].
    Serrallach N; Riera LL; Franco E; Aguiló F; Muñoz J; López-Costea MA; Camps N; Serra J; González C; Castelao AM
    Actas Urol Esp; 1994 Sep; 18(8):801-7. PubMed ID: 7998508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for malignancy in Japanese renal transplant recipients.
    Imao T; Ichimaru N; Takahara S; Kokado Y; Okumi M; Imamura R; Namba Y; Isaka Y; Nonomura N; Okuyama A
    Cancer; 2007 May; 109(10):2109-15. PubMed ID: 17407138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.